Crosstalk between IL‐15Rα(+) tumor‐associated macrophages and breast cancer cells reduces CD8(+) T cell recruitment

BACKGROUND: Interleukin‐15 (IL‐15) is a promising immunotherapeutic agent owing to its powerful immune‐activating effects. However, the clinical benefits of these treatments are limited. Crosstalk between tumor cells and immune cells plays an important role in immune escape and immunotherapy drug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenlong, Zhang, Qing, Yang, Nanfei, Shi, Qian, Su, Huifang, Lin, Tingsheng, He, Zhonglei, Wang, Wenxin, Guo, Hongqian, Shen, Pingping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198341/
https://www.ncbi.nlm.nih.gov/pubmed/35615815
http://dx.doi.org/10.1002/cac2.12311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198341/
https://www.ncbi.nlm.nih.gov/pubmed/35615815
http://dx.doi.org/10.1002/cac2.12311

Ejemplares similares